【ChiCTR2000038867】Minimally invasive hook-assisted reduction and cephalomedullary nailing for intertrochanteric femur fractures
ChiCTR2000038867
结束
/
/
/
2020-10-08
/
/
Intertrochanteric femur fracture
Minimally invasive hook-assisted reduction and cephalomedullary nailing for intertrochanteric femur fractures
Minimally invasive hook-assisted reduction and cephalomedullary nailing for intertrochanteric femur fractures
73200
In IFFs, it is necessary to anatomically reduce the medial hinge to perform stable osteosynthesis with an intramedullary implant. The displacement of broken fragments by strong muscles may not allow the fracture to be closed. In this study, it was aimed to evaluate hook-assisted reduction used in patients with IFFs used when reduction was difficult or the reduction provided was lost. Our hypothesis was that minimally invasive hook-assisted reduction would reduce surgical time and radiation exposure, and also improve radiologic results.
析因分组（即根据危险因素或暴露因素分组）
探索性研究/预试验
N/A
N/A
No
/
32;28
/
2019-09-24
2020-08-26
/
Between December 2015 and March 2019, 66 patients with IFFs who underwent osteosynthesis with cephalomedullary nailing were identified. One patient died in the early postoperative period, and five patients did not attend outpatient follow after being discharged. Accordingly, 60 patients were included in this study and evaluated retrospectively.；
请登录查看Patients were excluded if they had A1.1 type proximal femur fractures, collo-diaphyseal angle distortion less than 5 degrees from the opposite side, patients under 18 years, injuries present in the ipsilateral lower limb, patients with pathologic fractures, patients with follow-up less than 6 months, patients undergoing arthroplasty, and fractures fixed with implants other than intramedullary nails.；
请登录查看namik kemal university health hospital
59100
namik kemal university health hospital的其他临床试验
土耳其锡尔纳克州立医院的其他临床试验
- Minimally invasive hook-assisted reduction and cephalomedullary nailing for intertrochanteric femur fractures
- Evaluation of IL10 and TGF-beta levels in blood as a biomarker of peri-prosthetic joint infection
- Does the anterolateral ligament status have an effect on the preference of anterior cruciate ligament reconstruction in the patients with partial anterior cruciate ligament tears?
- Is cyclic exercise performed effective on grafts during ACL reconstruction?
- Procedural outcomes of double vs. single fluoroscopy for fixing supracondylar humerus fractures in children
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04